Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정진 | - |
dc.date.accessioned | 2022-02-22T16:31:04Z | - |
dc.date.available | 2022-02-22T16:31:04Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.issn | 2092-9900 | - |
dc.identifier.other | OAK-30789 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/260598 | - |
dc.description.abstract | Axillary ultrasonography (US) is the most commonly used imaging modality for nodal evaluation in patients with breast cancer. No Axillary Surgical Treatment in Clinically Lymph Node-Negative Patients after Ultrasonography (NAUTILUS) is a prospective, multicenter, randomized controlled trial investigating whether sentinel lymph node biopsy (SLNB) can be safely omitted in patients with clinically and sonographically node-negative T1-2 breast cancer treated with breast-conserving therapy. In this trial, a standardized imaging protocol and criteria were established for the evaluation of axillary lymph nodes. Women lacking palpable lymph nodes underwent axillary US to dismiss suspicious nodal involvement. Patients with a round hypoechoic node with effaced hilum or indistinct margins were excluded. Patients with T1 tumors and a single node with a cortical thickness >= 3 mm underwent US-guided biopsy. Finally, patients with negative axillary US findings were included. The NAUTILUS axillary US nodal assessment criteria facilitate the proper selection of candidates who can omit SLNB. | - |
dc.language | English | - |
dc.publisher | KOREAN BREAST CANCER SOC | - |
dc.subject | Breast Neoplasms | - |
dc.subject | Sentinel Lymph Node Biopsy | - |
dc.subject | Ultrasonography | - |
dc.title | Imaging Protocol and Criteria for Evaluation of Axillary Lymph Nodes in the NAUTILUS Trial | - |
dc.type | Article | - |
dc.relation.issue | 6 | - |
dc.relation.volume | 24 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.index | KCI | - |
dc.relation.startpage | 554 | - |
dc.relation.lastpage | 560 | - |
dc.relation.journaltitle | JOURNAL OF BREAST CANCER | - |
dc.identifier.doi | 10.4048/jbc.2021.24.e47 | - |
dc.identifier.wosid | WOS:000739858100003 | - |
dc.identifier.scopusid | 2-s2.0-85122016605 | - |
dc.author.google | Chang, Jung Min | - |
dc.author.google | Shin, Hee Jung | - |
dc.author.google | Choi, Ji Soo | - |
dc.author.google | Shin, Sung Ui | - |
dc.author.google | Choi, Bo Hwa | - |
dc.author.google | Kim, Min Jung | - |
dc.author.google | Yoon, Jung Hyun | - |
dc.author.google | Chung, Jin | - |
dc.author.google | Kim, Tae Hee | - |
dc.author.google | Han, Boo-Kyung | - |
dc.author.google | Kim, Hak Hee | - |
dc.author.google | Moon, Woo Kyung | - |
dc.contributor.scopusid | 정진(35573055900) | - |
dc.date.modifydate | 20230210134810 | - |